Zhan Yang

9PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)EndodonticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 12, 2026
CDK13 drives clear cell renal carcinoma through METTL16-mediated m<sup>6</sup>A modification of ACLY mRNA.

Jinsuo Chen, Huan Liu, Yong Zhang

|Oct 16, 2023
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA.

Yong Zhang, Xiao-Nan Chen, Hong Zhang

|Aug 16, 2023
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer.

Hongzhuang Wen, Changbao Qu, Zhu Wang

Pageof 2